BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29462172)

  • 1. Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.
    Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
    PLoS One; 2018; 13(2):e0192371. PubMed ID: 29462172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
    Zoia A; Drigo M; Piek CJ; Calcini H; Caldin M; Simioni P
    PLoS One; 2019; 14(11):e0225089. PubMed ID: 31725761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ascites and primary hyperfibrinolysis: A cohort study in 210 dogs.
    Zoia A; Drigo M; Simioni P; Caldin M; Piek CJ
    Vet J; 2017 May; 223():12-20. PubMed ID: 28671065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis in Dogs with Intracavitary Effusion: A Review.
    Zoia A; Drigo M; Caldin M; Simioni P; Piek CJ
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hemostatic and fibrinolytic markers in dogs with ascites attributable to right-sided congestive heart failure.
    Zoia A; Augusto M; Drigo M; Caldin M
    J Am Vet Med Assoc; 2012 Nov; 241(10):1336-43. PubMed ID: 23113526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of relevant indicators of coagulation and fibrinolysis in patients with varying severity of community-acquired pneumonia].
    Xu Y; Zhang Y; Jiang F; Zheng H; Zhang Y; Pang G; Yang L; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(24):1925-9. PubMed ID: 26710695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.
    Zoia A; Drigo M; Piek CJ; Simioni P; Caldin M
    J Vet Intern Med; 2017 Jan; 31(1):43-50. PubMed ID: 27862300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
    Widström O; Kockum C; Nilsson BS
    Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL; Amores Antequera C
    Eur J Med; 1992; 1(4):201-7. PubMed ID: 1341445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative plasma fibrinogen, but not D-dimer might represent a prognostic factor in non-metastatic colorectal cancer: A prospective cohort study.
    Hong T; Shen D; Chen X; Wu X; Hua D
    Cancer Biomark; 2017; 19(1):103-111. PubMed ID: 28269756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.
    Jandu N; Richardson M; Singh G; Hirte H; Hatton MW
    Int J Gynecol Cancer; 2006; 16(4):1536-44. PubMed ID: 16884362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
    Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
    Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of D -dimer in pleural effusion].
    Lü YD; Chen P; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):71-2. PubMed ID: 12212257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer levels in pleural effusions.
    Dikensoy O; Stathopoulos GT; Zhu Z; Light RW
    Respir Med; 2006 Aug; 100(8):1337-41. PubMed ID: 16427265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for D-dimer in the diagnosis of tuberculous pleural effusion.
    Shen Y; Yang T; Jia L; Wang T; Chen L; Wan C; Wang L; Yan Y; Yi Q
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):201-5. PubMed ID: 23377808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.
    Garcia-Pachon E; Soler MJ; Padilla-Navas I; Romero V; Shum C
    Respiration; 2005; 72(5):486-9. PubMed ID: 16210887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
    Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
    J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IL-6 elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients.
    Yamaguchi T; Kimura H; Yokota S; Yamamoto Y; Hashimoto T; Nakagawa M; Ito M; Ogura T
    Jpn J Clin Oncol; 2000 Feb; 30(2):53-8. PubMed ID: 10768866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
    Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
    Lung; 2006; 184(3):141-5. PubMed ID: 16902838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.